Analyzing the Price Movement - Analyst Research on StrikeForce Technologies, Greenshift, Progressive Care, and Endonovo Therapeutics

NEW YORK, NY / ACCESSWIRE / February 2, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: StrikeForce Technologies Inc. (SFOR), Greenshift Corp. (GERS), Progressive Care Inc. (RXMD) and Endonovo Therapeutics Inc. (ENDV). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

SFOR Research Package: http://www.traders-choice.com/pdf?s=SFOR

GERS Research Package: http://www.traders-choice.com/pdf?s=GERS

RXMD Research Package: http://www.traders-choice.com/pdf?s=RXMD

ENDV Research Package: http://www.traders-choice.com/pdf?s=ENDV

============

Highlights from today's reports include:

On Monday, February 1, 2016, NASDAQ Composite ended at 4,620.37, up 0.14%, Dow Jones Industrial Average declined 0.10%, to finish the day at 16,449.18, and the S&P 500 closed at 1,939.38, down 0.04%.

- StrikeForce Technologies Inc.'s stock edged lower by 35.71% to close Monday's session at USD 0.0009. The company's shares oscillated between USD 0.0008 and USD 0.0015. The stock recorded a trading volume of 106.69 million shares, much above its 50-day daily average volume of 8.98 million shares and its 52-week average volume of 1.95 million shares. Over the last three days StrikeForce Technologies Inc.'s shares have declined by 43.75% and in the past one week the stock has moved down 60.87%. Furthermore, over the last three months the stock has lost 79.55% and in the past six months the shares have shed 99.10%. On a compounded total return basis, the company has returned 80.14% in the past one month. The stock is trading below its 50-day and 200-day moving averages of USD 0.01 and USD 0.12, respectively. In addition, the stock is trading at a price to sales ratio of 0.05.

- The stock of Greenshift Corp. lost 11.76% to close Monday's session at USD 0.003. The shares of the company moved in the range of USD 0.0012 and USD 0.004. A trading volume of 5.91 million shares was recorded, which was greater than its 150-day daily average volume of 1.13 million shares and its 52-week average volume of 0.80 million shares. Over the last five days Greenshift Corp.'s shares have advanced 200.00%. Additionally, over the last three months the stock has advanced 66.67% and in the past six months the shares have registered a gain of 20.00%. The company has returned 328.51% in the past one month. Besides, the stock is trading below its 200-day moving average of USD 0.01. In addition, the stock is trading at a price to sales ratio of 0.04. The stock has an EV/Revenue multiple of 3.83.

- Progressive Care Inc.'s stock decreased by 0.77% to close Monday's session at USD 0.03. The company's shares fluctuated in the range of USD 0.02 and USD 0.03. A total of 1.89 million shares exchanged hands, which was lesser than its 50-day daily average volume of 6.72 million shares and its 52-week average volume of 5.09 million shares. Over the last three days Progressive Care Inc.'s shares have declined by 1.90% and in the past one week the stock has moved up 14.16%. However, over the last three months the stock has gained 180.43% and in the past six months the shares have picked up 203.53%. The stock is trading above its 50-day and 200-day moving averages of USD 0.02 and USD 0.01, respectively. In addition, the stock is trading at a price to sales ratio of 0.06 and a price to book ratio of 0.74.

- Endonovo Therapeutics Inc.'s stock added 66.29% to close Monday's session at USD 0.74. The company's shares oscillated between USD 0.44 and USD 0.79. The stock recorded a trading volume of 0.30 million shares, which was above its 50-day daily average volume of 0.12 million shares and its 52-week average volume of 0.06 million shares. Over the last five days Endonovo Therapeutics Inc.'s shares have advanced 97.33% and in the past one month the stock has gained a momentum of 94.74%. In addition, over the last three months the stock has gained 722.22% and in the past one year the shares have picked up 105.50%. Further, the company is trading at a price to earnings ratio of 0.01. Furthermore, the stock is trading above its 50-day moving average of USD 0.36 and its 200-day moving average of USD 0.23.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice